Replies to post #212447 on Biotech Values

[DewDiligence]

AGN acquires RPRX for $0.67/sh in cash:

https://globenewswire.com/news-release/2017/12/12/1252970/0/en/Repros-Therapeutics-Inc-Announces-Acquisition-by-Allergan-plc.html

Although the buyout is a 43% premium to yesterday's closing price, this is essentially a takeunder with a nominal deal price of only $27M.

RPRX has been a colossal failure for the past decade, as many readers of this board know.

No CC.